ESRD Choice Act of 2016

Summary

Expanding Seniors Receiving Dialysis Choice Act of 2016 or the ESRD Choice Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to allow individuals with end-stage renal disease (ESRD) to be eligible for Medicare Advantage (MA). Under current law, only individuals who develop ESRD while already enrolled in an MA plan may be considered eligible. With respect to payment, the bill: (1) shifts responsibility for the cost of kidney acquisitions from MA plans to Medicare's fee-for-service program, and (2) excludes such costs from the calculation of certain benchmarks that form the basis for payment under MA plans.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 7 July 2016

   Introduced

   Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 7 July 2016

   Introduced

   Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

3. 7 July 2016

   Introduced

   Introduced in House

   Source: IntroReferral

4. 7 July 2016

   Introduced

   Introduced in House

   Source: IntroReferral

5. 8 July 2016

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

6. 13 July 2016

   Reported

   Ordered to be Reported (Amended) by Voice Vote.

   Source: Committee

7. 13 July 2016

   Committee

   Committee Consideration and Mark-up Session Held.

   Source: Committee

8. 19 September 2016

   Reported

   Reported (Amended) by the Committee on Ways and Means. H. Rept. 114-751, Part I.

   Source: Committee

9. 19 September 2016

   Reported

   Reported (Amended) by the Committee on Ways and Means. H. Rept. 114-751, Part I.

   Source: Committee

10. 19 September 2016

    Calendars

    Placed on the Union Calendar, Calendar No. 583.

    Source: Calendars

11. 19 September 2016

    Discharge

    Committee on Energy and Commerce discharged.

    Source: Discharge

12. 19 September 2016

    Committee

    Committee on Energy and Commerce discharged.

    Source: Committee

13. 20 September 2016

    Vote

    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

    Source: Floor

14. 20 September 2016

    Floor

    Considered under suspension of the rules. (consideration: CR H5679-5681)

    Source: Floor

15. 20 September 2016

    Floor

    DEBATE - The House proceeded with forty minutes of debate on H.R. 5659.

    Source: Floor

16. 20 September 2016

    Floor

    Mr. Smith (MO) moved to suspend the rules and pass the bill, as amended.

    Source: Floor

17. 21 September 2016

    Passed

    Motion to reconsider laid on the table Agreed to without objection.

    Source: Floor

18. 21 September 2016

    Vote

    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 423 - 0 (Roll no. 529). (text: CR 09/20/2016 H5679-5680)

    Source: Floor

19. 21 September 2016

    Vote

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 423 - 0 (Roll no. 529).(text: CR 09/20/2016 H5679-5680)

    Source: Floor

20. 21 September 2016

    Floor

    Considered as unfinished business. (consideration: CR H5739)

    Source: Floor

21. 22 September 2016

    Introduced

    Received in the Senate and Read twice and referred to the Committee on Finance.

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Referred in Senate · 22 September 2016 · Official file
• Engrossed in House · 21 September 2016 · Official file
• Reported in House · 19 September 2016 · Official file
• Introduced in House · 7 July 2016 · Official file

Documents

11 official files

• Referred in Senate (text)

  Referred in Senate · EN · 22 September 2016

  ViewDownloadOpen at official source

• Referred in Senate (PDF)

  Referred in Senate · EN · 22 September 2016

  ViewDownloadOpen at official source

• Engrossed in House (text)

  Engrossed in House · EN · 21 September 2016

  ViewDownloadOpen at official source

• Engrossed in House (PDF)

  Engrossed in House · EN · 21 September 2016

  ViewDownloadOpen at official source

• Passed House amended

  summary · EN · 21 September 2016

  Open at official source

• Reported in House (text)

  Reported in House · EN · 19 September 2016

  ViewDownloadOpen at official source

• Reported in House (PDF)

  Reported in House · EN · 19 September 2016

  ViewDownloadOpen at official source

• Reported to House amended, Part I

  summary · EN · 19 September 2016

  Open at official source

• Introduced in House (text)

  Introduced in House · EN · 7 July 2016

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 7 July 2016

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 7 July 2016

  Open at official source

Sponsors

• Rep. Smith, Jason [R-MO-8] · R · Sponsor
• JOHN LEWIS · D · Sponsor
• Rep. Bilirakis, Gus M. [R-FL-12] · R · Sponsor
• Kurt Schrader · D · Sponsor
• Tom Marino · R · Sponsor
• Gregg Harper · R · Cosponsor
• Peter Roskam · R · Cosponsor
• Todd Young · R · Cosponsor
• Kyrsten Sinema · D · Cosponsor
• JOE BARTON · R · Cosponsor
• Lynn Jenkins · R · Cosponsor
• Linda Sánchez · D · Cosponsor
• · ssfi00 · Standing
• · hsif00 · Standing
• · hswm00 · Standing

Related records

• related to → 21st Century Cures Act